The company has received the import and market permission in Form CT-20 from the Drugs Controller General of India for Selumetinib 10 mg 25 mg capsules, AstraZeneca Pharma India said in a regulatory filing.from Moneycontrol Business News https://ift.tt/3icwLZU
Comments
Post a Comment